Trough serum infliximab is a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis, reports January's issue of Gut.

The most recent issue of Endoscopy evaluates process quality and incidence of acute complications in a series of more than 230,000 outpatient colonoscopies.

A team of doctors are developing international classification core sets for patients with inflammatory bowel diseases based on the international classification of functioning, disability, and health§, reports the latest Inflammatory Bowel Diseases.